Grik4 Protein Glutamate Receptor Kainate Type Subunit 8 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GRIK4 Protein (GluR8/Kainate receptor subunit 8) is encoded by the GRIK4 gene. It is a high-affinity kainate receptor subunit belonging to the ionotropic glutamate receptor family. GRIK4 forms functional kainate receptors when assembled with other subunits (GRIK1, GRIK2, GRIK3, or GRIK5), contributing to excitatory the central synaptic transmission throughout nervous system.
| Attribute |
Value |
| Protein Name |
Glutamate receptor kainate 8 |
| Gene |
GRIK4 |
| UniProt ID |
Q9UFL4 |
| Molecular Weight |
~104 kDa |
| Subcellular Localization |
Plasma membrane (postsynaptic density) |
| Protein Family |
Ionotropic glutamate receptor (kainate) |
| Amino Acids |
956 |
| Gene Location |
Chromosome 21q21.3 |
GRIK4 contains several distinct structural domains that mediate its function:
- Extracellular N-terminus: Contains the ligand-binding domain (LBD) formed by two polypeptide segments (S1 and S2), responsible for glutamate binding
- Transmembrane domain: Three membrane-spanning helices (M1, M3, M4) that form the ion channel pore
- C-terminal intracellular tail: Involved in protein-protein interactions, trafficking, and regulation
The ligand-binding domain exhibits high affinity for glutamate and related agonists, distinguishing GRIK4 from other kainate receptor subunits. This high-affinity binding is mediated by specific amino acid residues in the LBD that create a favorable binding pocket for kainate and glutamate.
GRIK4-containing kainate receptors play important roles in excitatory neurotransmission:
- Synaptic plasticity: Contribute to both short-term and long-term plasticity at various synapses
- Circuit formation: Important for neuronal circuit development and refinement during development
- Calcium signaling: Permits calcium influx through the receptor channel, triggering downstream signaling cascades
GRIK4 shows distinct expression patterns:
- Hippocampus: High expression in CA3 region and dentate gyrus
- Cerebral cortex: Layer-specific expression in cortical neurons
- Amygdala: Modulates emotional processing and learning
- Cerebellum: Present in granule cells and molecular layer interneurons
GRIK4 can assemble with multiple partner subunits:
- GRIK4/GRIK5: High-affinity homomeric and heteromeric receptors
- GRIK4/GRIK2: Heteromeric receptors with intermediate properties
- GRIK4/GRIK1: Lower-affinity receptor combinations
The diversity of assembly options allows fine-tuning of receptor properties to match circuit requirements.
GRIK4 is implicated in Alzheimer's disease through multiple mechanisms:
- Glutamate excitotoxicity: Dysregulation of kainate receptors may contribute to excitotoxic cell death
- Amyloid interaction: Aβ oligomers can modulate kainate receptor function
- Synaptic dysfunction: Altered GRIK4 expression correlates with synaptic loss in AD models
- Genetic association: GWAS studies have identified GRIK4 variants as potential AD risk factors
¶ Depression and Psychiatric Disorders
- Serotonergic interaction: GRIK4 interacts with serotoninergic systems implicated in mood regulation
- Antidepressant response: Genetic variants in GRIK4 may predict response to certain antidepressants
- Bipolar disorder: Association studies suggest potential links to mood disorders
- Seizure susceptibility: GRIK4 mutations can alter neuronal excitability
- Absence seizures: Specific GRIK4 variants have been linked to absence epilepsy
- Therapeutic target: Kainate receptor antagonists are being explored for seizure control
- Schizophrenia: Altered GRIK4 expression in postmortem brain tissue
- Autism spectrum disorders: Potential involvement in excitatory/inhibitory balance
- Migraine: Possible role in cortical spreading depression
- Glutamate: Endogenous agonist
- Kainic acid: Potent synthetic agonist used experimentally
- ATPA: Selective agonist for GluR5-containing receptors (GRIK4)
- CNQX: Competitive antagonist
- NBQX: AMPA/kainate receptor antagonist
- LY466365: Selective GluR5 antagonist
Kainate receptor modulation remains an active area of drug development:
- Neuroprotective strategies: Blocking excessive kainate receptor activation
- Antidepressant development: Targeting specific subunits
- Anti-epileptic drugs: Modulating hyperexcitability
- How do GRIK4-containing receptors differ functionally from other kainate receptors?
- What is the precise role of GRIK4 in AD pathophysiology?
- Can selective GRIK4 modulators be developed therapeutically?
- CRISPR models: GRIK4 knockout and knock-in mice
- iPSC neurons: Patient-derived neurons for disease modeling
- Single-cell RNAseq: Understanding cell-type specific expression
The study of Grik4 Protein Glutamate Receptor Kainate Type Subunit 8 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.